- Home
- VANI vs NSPR Comparison
VANI vs NSPR Comparison
Compare VANI & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- NSPR
- Stock Information
- Founded
- VANI 1998
- NSPR 2005
- Country
- VANI United States
- NSPR United States
- Employees
- VANI N/A
- NSPR N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NSPR Medical/Dental Instruments
- Sector
- VANI Health Care
- NSPR Health Care
- Exchange
- VANI Nasdaq
- NSPR Nasdaq
- Market Cap
- VANI 68.1M
- NSPR 79.7M
- IPO Year
- VANI 2014
- NSPR N/A
- Fundamental
- Price
- VANI $1.26
- NSPR $2.56
- Analyst Decision
- VANI Strong Buy
- NSPR Strong Buy
- Analyst Count
- VANI 1
- NSPR 2
- Target Price
- VANI $4.00
- NSPR $4.50
- AVG Volume (30 Days)
- VANI 66.4K
- NSPR 53.1K
- Earning Date
- VANI 05-13-2025
- NSPR 05-09-2025
- Dividend Yield
- VANI N/A
- NSPR N/A
- EPS Growth
- VANI N/A
- NSPR N/A
- EPS
- VANI N/A
- NSPR N/A
- Revenue
- VANI N/A
- NSPR $7,027,000.00
- Revenue This Year
- VANI N/A
- NSPR $27.41
- Revenue Next Year
- VANI N/A
- NSPR $127.08
- P/E Ratio
- VANI N/A
- NSPR N/A
- Revenue Growth
- VANI N/A
- NSPR 8.49
- 52 Week Low
- VANI $0.91
- NSPR $2.07
- 52 Week High
- VANI $2.09
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- VANI 77.37
- NSPR 54.34
- Support Level
- VANI $1.13
- NSPR $2.42
- Resistance Level
- VANI $1.16
- NSPR $2.60
- Average True Range (ATR)
- VANI 0.05
- NSPR 0.15
- MACD
- VANI 0.02
- NSPR 0.03
- Stochastic Oscillator
- VANI 92.86
- NSPR 75.93
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.